Sang-Yong Park
Director/Miembro de la Junta en GS GLOBAL CORP. .
Perfil
Sang-Yong Park is currently an Independent Director at GS Global Corp., a Director at Immunomic Therapeutics, Inc., and a Trustee at East Asia Institute.
He previously worked as the Chief Executive Officer at Macquarie Securities Korea Ltd.
Park received his graduate degree from The Trustees of Columbia University in The City of New York in 1992 and his undergraduate degree from the University of California in 1990.
Cargos activos de Sang-Yong Park
Empresas | Cargo | Inicio |
---|---|---|
GS GLOBAL CORP. | Director/Miembro de la Junta | 24/03/2017 |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Director/Miembro de la Junta | 27/07/2021 |
East Asia Institute | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Sang-Yong Park.
Empresas | Cargo | Fin |
---|---|---|
Macquarie Securities Korea Ltd.
Macquarie Securities Korea Ltd. Investment Banks/BrokersFinance Macquarie Securities Korea Ltd. (MSKL) is the South Korean broker/dealer subsidiary of Great Britain-based Macquarie Internationale Investments Ltd., ultimately held by Macquarie Group Ltd. (ASX: MQG) in Australia. Headquartered in Seoul, MSKL was founded in 2006 and offers cash equities broking and risk and arbitrage trading services. | Director Ejecutivo | - |
Formación de Sang-Yong Park.
University of California | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GS GLOBAL CORP. | Distribution Services |
Empresas privadas | 3 |
---|---|
Macquarie Securities Korea Ltd.
Macquarie Securities Korea Ltd. Investment Banks/BrokersFinance Macquarie Securities Korea Ltd. (MSKL) is the South Korean broker/dealer subsidiary of Great Britain-based Macquarie Internationale Investments Ltd., ultimately held by Macquarie Group Ltd. (ASX: MQG) in Australia. Headquartered in Seoul, MSKL was founded in 2006 and offers cash equities broking and risk and arbitrage trading services. | Finance |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
East Asia Institute |
- Bolsa de valores
- Insiders
- Sang-Yong Park